MGRX (MangoRx) EV/Sales Multiple

Public company logo of Mangoceuticals Inc. (MGRX)

Mangoceuticals, Inc. is fighting for position in the overheated men's health segment through viral marketing. The enterprise value-to-revenue multiple visualizes this trend, where 18566.67 determines the latest valuation metric. Rising licensing costs and user trust create barriers, while the market share retention strategy relies on sponsorship partnerships without pursuing M&A transactions.

MGRX (Mangoceuticals Inc.) EV/Sales Multiple history from 11/23/2025 to 11/20/2026

Mangoceuticals, Inc. - analytical breakdowns and key metrics (MGRX)

- price and consensus price forecast:
Initial company analysis:MangoRx - MGRX
Manufactured product of MangoRx

This indicator measures the total value of the business, including debt and equity, relative to sales volume, allowing for an assessment of the asset's market value regardless of its financing method. For Mangoceuticals, Inc. (MGRX), a stable EV/Revenue chart confirms the effective monetization of telemedicine services and the predictability of revenue driven by steady demand for prescription drugs.